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Chromosomal translocations involving antigen receptor loci are common in lymphoid malignan-
cies. Translocations require DNA double-strand breaks (DSBs) at two chromosomal sites, their
physical juxtaposition, and their fusion by end-joining. Ability of lymphocytes to generate diverse
repertoires of antigen receptors and effector antibodies derives from programmed genomic alter-
ations that produce DSBs. We discuss these lymphocyte-specific processes, with a focus on
mechanisms that provide requisite DSB target specificity and mechanisms that suppress DSB
translocation. We also discuss recent work that provides new insights into DSB repair pathways
and the influences of three-dimensional genome organization on physiological processes and
cancer genomes.Introduction
The B cell antigen receptor (BCR) comprises immunoglobulin (Ig)
heavy (IgH) and light (Igk or Igl, collectively called IgL) chains.
The T cell antigen receptor (TCR) is highly related. TheN-terminal
variable region of Ig and TCR chains binds antigen and is
encoded by germline V, D, and J gene segments, which are
assembled into V(D)J exons in developing B and T lymphocytes
(Cobb et al., 2006; Krangel, 2009). V(D)J recombination contrib-
utes to diverse antigen receptor repertoires by assembling the
numerous V (variable), D (diversity), and J (joining) gene seg-
ments in different combinations (Davis and Bjorkman, 1988).
Transcription from a V promoter runs through the assembled
V(D)J exon and several downstream exons that encode a
C-terminal ‘‘constant’’ region. Upon antigen activation, mature
B cells undergo two additional genomic alterations. Somatic
hypermutation (SHM) introduces point mutations into IgH and
IgL variable region exons, allowing selection of B cells that
produce higher-affinity antibodies (Di Noia and Neuberger,
2007). IgH class switch recombination (CSR) replaces one set
of IgH constant region exons (CHs) with another, allowing B
cells to secrete different effector antibody classes containing
the variable region that contributed to their BCR (Chaudhuri
et al., 2007). In both mice and humans, antigen receptor loci lie
on different chromosomes or distal parts of a given chromo-
some, spanning large distances. Antigen receptor loci also con-
tain strong regulatory regions that contribute to both assembly
and expression of Ig and TCR genes (Cobb et al., 2006; Krangel,
2009).
The V(D)J recombination process has distinct cutting and
joining components, rather than being carried out by a single
‘‘recombinase.’’ The lymphocyte-specific RAG endonuclease
(‘‘RAG’’), comprising recombination activating gene 1 and 2
proteins, initiates the reaction by introducing DSBs adjacent totarget Vs, Ds, and Js, which are collectively referred to as
‘‘coding segments’’ (Schatz and Baltimore, 2004). These DSBs
are fused to complete V(D)J recombination by classical nonho-
mologous end-joining (C-NHEJ), a major general cellular DSB
repair pathway (Boboila et al., 2012). CSR also has distinct
initiating and joining components. Activation-induced cytidine
deaminase (AID), which initiates both CSR and SHM, is required
for generation of DSBs in downstream portions of IgH (Honjo
et al., 2002). Such DSBs are joined, largely, by C-NHEJ to
complete CSR (Boboila et al., 2012). Generation of functional
antigen receptor loci via DSB intermediates poses great onco-
genic risks, as DSBs initiate chromosomal translocations (Zhang
et al., 2010). This risk is compounded by the ability of antigen
receptor locus regulatory elements to activate translocated
oncogene expression (Janz, 2006). Thus, V(D)J-recombination-
associated DSBs in antigen receptor loci lead to oncogenic
translocations found in human B or T cell acute lymphoblastic
leukemias (i.e., B-ALLs and T-ALLs) that arise from developing
lymphocytes, as well as translocations found in more mature B
cell lymphomas (Gostissa et al., 2011; Robbiani and Nussenz-
weig, 2012). In addition, CSR-associated DSBs give rise to IgH
translocations found in human mature B cell lymphomas and
multiple myeloma (Gostissa et al., 2011; Robbiani and Nussenz-
weig, 2012). Translocations that fuse the c-myc oncogene to IgH
occur in many human Burkitt’s lymphomas and have provided
classic examples of both RAG- and AID-initiated translocations
(Gostissa et al., 2011; Robbiani and Nussenzweig, 2012).
Despite these risks, lymphoid tumors with antigen receptor locus
translocations occur only in a small fraction of individuals, as
checkpoints eliminate most cells with unrepaired DSBs or onco-
genic translocations (Lowe et al., 2004). In addition, risks are
further minimized by strict regulation of the formation of antigen
receptor locus DSBs and processes that join them.Cell 152, January 31, 2013 ª2013 Elsevier Inc. 417
Figure 1. Repair of RAG-Induced Antigen Receptor Locus DSBs by
Classical Nonhomologous End-Joining
(A) RAG1 and -2 (yellow and orange ovals) are targeted to participating gene
segments in the context of the 12/23 rule. Triangles represent 12-RSSs (blue)
and 23RSSs (white), and boxes represent potential coding segments.
(B and C) RAG holds cleaved hairpin coding and blunt RSS ends in a post-
cleavage synaptic complex (PSC) (B) and directs the reaction into C-NHEJ
initiated by Ku70 and Ku80 (dark and light purple ovals) binding (C).
(D) Coding ends require processing, and N regions can be added by TdT (gray
oval), whereas (E) RSS ends are directly ligated by the XRCC4 (yellow oval)/
Lig4 (red oval) complex to form coding and RSS joins, respectively. Functional
redundancy of DDR and XLF in this reaction is indicated by ATM, 53BP1, and
H2AX ovals separated by a line from an XLF oval. Specifically, coding joins are
modestly impaired in the absence of the ATM and 53BP1 DDR factors and are
normal in the absence of the H2AX DDR factor or XLF C-NHEJ factor.
However, coding joins are severely impaired in the combined absence of XLF
and any one of the three DDR factors. RSS joins are normal in the absence of
any one of the DDR factors or XLF but are severely impaired in the absence of
ATM or 53BP1 (H2AX was not tested) and XLF.Mechanism and Control of V(D)J Recombination
V(D)J Recombination Initiation
RAGwas discovered based on ability to confer V(D)J recombina-
tion to nonlymphoid cells (Schatz and Baltimore, 2004). RAG
generates DSBs between two coding segments and short re-
combination signal sequences (RSSs) that flank them and then
holds these ends in a postcleavage synaptic complex (Figures
1A and 1B). Subsequently, the two coding segment ends are418 Cell 152, January 31, 2013 ª2013 Elsevier Inc.joined to form ‘‘coding joins’’ (Figures 1C and 1D), and the two
RSS ends are joined to form ‘‘RSS joins’’ (Figures 1C and 1E)
(Schatz and Swanson, 2011). In this way, the V(D)J recombina-
tion process provides an inherent chromosomal directionality
to V(D)J recombination that is dependent on relative orientation
of participating gene segments (Bassing et al., 2002). RAG
restricts joining to C-NHEJ, with other DSB repair pathways
excluded by RAG2 (Corneo et al., 2007). V(D)J recombination
occurs in the G1 cell-cycle phase, ensured by rapid RAG2
degradation at the G1/S transition (Desiderio, 2010). Limiting
the reaction to G1 solidifies repair pathway choice and facilitates
higher-order regulation. Though truncated RAGs have robust
transposase activity, reflecting their evolutionary origin, these
activities are suppressed in the context of full-length RAGs
(Chatterji et al., 2004). RSSs comprise a palindromic heptamer
and an AT-rich nonamer separated by spacers of 12 or 23
base pairs (referred to as ‘‘12RSSs’’ and ‘‘23RSSs’’). Joining
two coding segments follows the ‘‘12/23 rule’’; to be cut by
RAG, they must be flanked, respectively, by ‘‘complementary’’
12- and 23RSSs (Schatz and Swanson, 2011; Figure 1). The
12/23 restriction helps to guide V(D)J recombination. For
example, all VHs are flanked by 23RSSs, DHs on both sides by
12RSSs, and JHs by 23RSSs, preventing direct VH-to-JH joining
and necessitating formation of a full V(D)J exon. A beyond 12/23
(‘‘B12/23’’) restriction also guides joining. TCR Vbs are flanked
by 23RSSs, Dbs by 12- and 23RSSs, and Jbs by 12RSSs. Yet,
Vbs do not join directly to Jbs but can if a Jb 12RSS is replaced
with a Db 12RSS (Schatz and Swanson, 2011). The 12/23 and,
potentially, B12/23 restrictions help to minimize ‘‘off-target’’
RAG activity by limiting cleavage to sequences flanked by
complementary RSS pairs. This is important because functional
RSSs vary from the consensus, allowing abundant genomic
representation of ‘‘cryptic’’ RSSs (Tsai and Lieber, 2010).
Developmental Regulation of V(D)J Recombination
RAG expression and V(D)J recombination occur exclusively
within lymphocyte lineages and primarily in developing lympho-
cytes, largely limiting RAG-initiated genomic instability to these
cells. Within developing lymphocytes, V(D)J recombination is
regulated by higher-order mechanisms to ensure faithful and
representative cleavage and joining of widely separated Vs,
Ds, and Js (Cobb et al., 2006). Most broadly, assembly of
complete Ig and TCR variable region exons is ‘‘lineage specific,’’
occurring only in B- and T-lineage cells, respectively. Within
each lineage, V(D)J recombination is further regulated to ensure
diverse and specific repertoires and to prevent undesired rear-
rangements. For the major a/b T cell lineage, relationships
between V(D)J recombination and development are similar
to those of B cells (Bassing et al., 2002; Krangel, 2009). There-
fore, we focus mainly on B cell development and IgH, which
undergoes all forms of mammalian antigen receptor gene diver-
sification.
Productive IgH and IgL variable region exon assembly, leading
to generation of IgH and IgL chains, directs B cell developmental
progression (Figure 2A). IgH V(D)J recombination occurs ‘‘stage
specifically’’ before that of IgL in progenitor (‘‘pro’’) B cells and is
‘‘ordered,’’ with D-to-JH joining occurring before VH appendage
to DJH complexes (Cobb et al., 2006). Indeed, VHs are not joined
to unrearranged DHs, even though compatible with 12/23 and
Figure 2. Regulation of V(D)J Recombination during B Cell
Development
(A) B cell development is directed by ordered assembly of IgH and IgL genes
coupled with feedback mechanisms linking IgH and IgL expression to devel-
opmental progression.
(B) During the D-to-JH rearrangement stage in early pro-B cells, prevention of
premature, unordered proximal VH rearrangements to germline Ds requires
the two IGCR1 CBEs, which may functionally segregate the D and JH portion
of the locus (blue rectangle). Gene segments and elements are indicated with
the most proximal VH segment (VH81X) shown as a black rectangle. CBEs are
indicated as extended pink arrowheads with vertical direction indicating
relative sequence orientation. Known, robust germline VH transcription is
indicated by thick green lines, and very low-level germline VH transcription is
indicated by a thin dotted green line. Known or hypothesized iEm-mediated
transcriptional activation is indicated by red arrows.
(C) In early pro-B cells in which the IGCR1 CBEs are inactivated (red crosses),
the functional segregation of the D and JH portions of the IgH locus extends to
the proximal VHs, deregulating their transcription and rearrangement, espe-
cially VH81X . Distal VHs are physically unavailable for recombination in these
cells due to lack of locus contraction.
(D) In the late pro-B stage subsequent to DJH rearrangement, IGCR1 CBE
activities must be neutralized (gray box) to allow VH segments to enter into
VH-to-DJH recombination centers (also indicated by blue rectangles). IgHB12/23 restrictions. Due to imprecise end-joining, about one in
three V(D)J junctions generates an IgH m chain. Association of
a m chain with a ‘‘surrogate’’ IgL chain forms a ‘‘pre-B receptor’’
(Melchers et al., 2000; Rajewsky, 1996), which gives a ‘‘feed-
back’’ signal to prevent rearrangement of the other allele if in
DJH configuration (Mostoslavsky et al., 2004) and to promote
the onset of IgL V(D)J recombination at the precursor (‘‘pre’’) B
stage (Cobb et al., 2006). Igk V(D)J recombination usually occurs
before that of Igl, with most Igl B cells derived from pre-B cells
that, via V(D)J recombination, inactivated both Igks (Cobb et al.,
2006). Association of IgL chains with m IgH chains to form nonau-
toreactive BCRs downregulates RAG in newly generated B cells.
However, if the BCR is autoreactive, continued RAG expression
promotes ‘‘receptor editing’’ in which the productive VLJL is re-
placed by another one, potentially generating a nonautoreactive
BCR (Nemazee, 2006).
Higher-Order Regulation of V(D)J Recombination
Lineage, stage, order, and feedback regulation of V(D)J recom-
bination are mediated ‘‘epigenetically’’ by modulating ‘‘accessi-
bility’’ of particular loci or regions of loci to RAG (Sleckman and
Oltz, 2012). Mouse IgH contains several hundred VHs, 13 Ds,
and 4 JHs in an 3 Mb region upstream of the CHs (Figures 2B
and 3). V(D)J recombinational accessibility and transcription
are tightly correlated in IgH. In this regard, the JH-to-Cm intronic
enhancer (‘‘iEm’’) is required for VH-to-DJH joining, but not for
D-to-JH joining, which relies on undefined accessibility elements
(Subrahmanyam and Sen, 2012). Transcription of unrearranged
(‘‘germline’’) VHs in pro-B cells that is downregulated in more
mature stages was the first accessibility correlate for V(D)J
recombination (Sleckman and Oltz, 2012). Widespread anti-
sense transcription also occurs throughout the VH locus (Mathe-
son and Corcoran, 2012). Though it has been debated as
to whether transcription directly leads to accessibility (Cobb
et al., 2006), these two processes were linked in the TCRa and
TCRb loci (Abarrategui and Krangel, 2007; Cobb et al., 2006).
In addition, there are numerous epigenetic accessibility corre-
lates, such as the histone H3 lysine 4 trimethylation (H3K4Me3)
transcriptional mark enriched around JHs in early pro-B cells in
association with germline transcription (Subrahmanyam and
Sen, 2012). The C-terminal RAG2 plant homeodomain (PHD)
binds H3K4Me3, recruiting RAG2 to transcribed genomic regions
with RAG1 binding to RSSs (Desiderio, 2010; Matthews and
Oettinger, 2009; Schatz and Swanson, 2011). Such binding
specificities accumulate RAG1 and RAG2 within recombination
‘‘centers,’’ where they capture complementary RSSs and initiate
V(D)J recombination (Schatz and Ji, 2011; Matthews and Oet-
tinger, 2009).
VH-to-DJH joining, as opposed to D to JH joining, is regulated in
the context of lineage, order, and feedback, which suggested
that the VH-to-D intergenic regionmight contain potential regula-
tory elements (Matheson and Corcoran, 2012). In this regard,locus contraction occurs at this stage to bring distal VHs closer to already
recombined DJHs. At this stage, both proximal (left) and distal (right) VHs may
enter into a recombination center, drawn in this case as occurring in two
individual cells, although this process has not yet been dissected at this level.
Red question marks indicate other speculated aspects of the process that
have not been tested experimentally.
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Figure 3. AID Targeting during SHM and IgH CSR
(A) Organization of an expressed IgH locus with general location of V(D)J exon, iEm, 30IgHRR (30RR) and CHs, S regions, and I region promoters (line/arrow).
(B) During SHM in GC B cells, AID targets transcribed IgH V(D)J exons leading to mutations (red circles) but does not necessarily target downstream S regions.
(C) During CSR, in activated B cells in culture, AID targets transcribed S regions leading to somatic mutations and DSBs (jagged gaps) but not adjacent V(D)J
exons. AID-initiated DSBs in S regions can be joined to form intra-S deletions (ISDs) (truncated S region oval with black center) or CSR events (fused S region
ovals). CSR is thought to occur by a deletional mechanism with intervening sequences deleted on an excision circle.
(D) Working model for transcriptional AID targeting (adapted from Basu et al., 2011). U, deaminated cytidines; RPA, replication protein A; RNAP II, RNA
polymerase II.targeted mutation of two closely linked CTCF-binding elements
(CBEs) within the downstream portion of the VH-D intergenic
region led to premature transcriptional activation of D-proximal
VHs along with associated epigenetic modifications; corre-
spondingly, these CBEmutations also abrogated lineage, stage,
and feedback control of proximal VH rearrangement (Guo et al.,
2011b; Figure 2B). Balancing antibody repertoires requires
representation of all VHs in the vast newly generated pre-B cell
population, providing a ‘‘primary’’ repertoire for molding by cel-
lular selection (Melchers et al., 2000; Rajewsky, 1996). Though
D-proximal VHs normally rearrange more frequently than ‘‘distal’’
VHs in WT pro-B cells, the most D-proximal VH (‘‘VH81X’’) greatly
predominates on VH-D intergenic CBE mutant alleles (Guo et al.,
2011b; Figure 2B). Thus, the VH-D intergenic CBEs help to
balance primary VH(D)JH repertoires by suppressing premature,
unordered rearrangement of themost proximal VHs, thereby pre-
venting them from blocking DJH substrates for distal VH rear-
rangements (Guo et al., 2011b). Consistent with roles in other
loci (Phillips and Corces, 2009), these VH-D intergenic CBE
suppressive functions may involve sequestration of the D and
JH portion of IgH within a distinct regulatory domain at the
D-to-JH rearrangement stage to insulate proximal VHs from pre-
mature activation by iEm or other elements (Degner et al., 2011;
Guo et al., 2011b; Figure 2B). Obviously, such insulating activi-
ties somehow must be neutralized or circumvented following
formation of DJHs to allow joining of VHs (Figure 2C).420 Cell 152, January 31, 2013 ª2013 Elsevier Inc.The mouse IgH has a remarkable number and organization
of CBEs (Bossen et al., 2012; Degner et al., 2011), which are
largely conserved in humans. In addition to two VH-D intergenic
CBEs, there are 10 CBEs (‘‘30CBEs’’) clustered just downstream
of IgH, a CBE adjacent to each proximal VH RSS, as well as CBEs
interspersed between distal VH clusters (Figure 2B). Notably, the
two VH-D intergenic CBEs have opposite orientations, and the
30CBEs and VH CBEs have opposite orientations in both mouse
and human (Guo et al., 2011b; Bryne et al., 2008). Given possible
orientation-specific CBE activity (MacPherson and Sadowski,
2010), this striking organization may contribute to overall CBE
function within IgH. In this regard, different aspects of IgH CBE
organization might contribute different functions; for example,
suppression versus activation of VH-to-DJH rearrangement (Bos-
sen et al., 2012; Guo et al., 2011b). In pro-B cells, the intergenic
CBE locale forms loops with the iEm locale, which lacks CBEs, as
well as with the 30CBEs and with some VH locales (Degner et al.,
2011; Guo et al., 2011a, 2011b). Potential roles for such loops
in regulation of IgH V(D)J recombination have been speculated
(Degner et al., 2011; Guo et al., 2011a, 2011b) but not yet directly
tested. Indeed, deletion of eight CBEs of the ten 30CBEs had no
obvious impact on IgH V(D)JH recombination (Volpi et al., 2012);
however, the two remaining 30CBEs might still provide requisite
functions.
A more general question is how CTCF binding to CBEs medi-
ates specific regulatory events, given that CTCF binds numerous
genomic CBEs and occupies IgH CBEs throughout B cell devel-
opment (Degner et al., 2011). Bound CTCF activities may be
influenced by interacting proteins, such as cohesin (Degner
et al., 2011), which regulates TCRa transcription and recombina-
tion (Seitan et al., 2011). In addition, bound CTCF activity could
bemodified by other factors binding in close proximity. In this re-
gard, the two VH-D intergenic CBEs have been speculated to
belong to a greater regulatory region termed intergenic control
region-1 (IGCR1), which also contains binding sites for other
factors, including Pax5 and YY1 (Guo et al., 2011b), which are
implicated in control of IgH V(D)J recombination and/or forma-
tion of various loops within IgH that could influence V(D)J recom-
bination (Degner et al., 2011; Ebert et al., 2011; Guo et al., 2011a;
see below). Potential roles for these and other factors in medi-
ating IGCR1 CBE-specific or other regulatory events should be
clarified by mutation of these binding sites within IGCR1 or in
other IgH regions. Finally, comparison of the effects of deleting
the entire VH-D intergenic region (Giallourakis et al., 2010) with
those of deleting just IGCR1 suggests that the VH-D interval
contains additional regulatory elements that influence genera-
tion of long antisense transcripts initiated in the downstream
DH cluster (see Supplemental Discussion in Guo et al., 2011b).
Balancing primary VH repertoires relies greatly on large-scale
‘‘repositioning’’ of the distal VHs into close physical proximity
with the DJHs (Figure 2C). This ‘‘locus contraction,’’ which
involves formation of chromosomal loops or rosettes (Bossen
et al., 2012; Hewitt et al., 2010), is critical for distal VH utilization
and requires several transcription factors, including Pax5, YY1,
and Ezh-2, (Hewitt et al., 2010; Medvedovic et al., 2011). As
distal VHs in ‘‘decontracted’’ IgH loci in Pax5-deficient pro-B
cells remain robustly transcribed, locus contraction provides
accessibility via physical juxtaposition, as opposed to more
standard chromatin-mediated forms of epigenetic accessibility
(Hewitt et al., 2010; Medvedovic et al., 2011; Figure 2C). Locus
contraction does not require the VH-D intergenic CBEs (Guo
et al., 2011b), although these elements may still promote more
local interactions between VHs and DJHs of contracted loci
that contribute to their synapsis in recombination centers (Bos-
sen et al., 2012; Guo et al., 2011a, 2011b). Candidates for
upstream elements that contribute to IgH locus contraction are
the Pax5-activated intergenic region (PAIR) elements, which
contain CBEs, promoters, and Pax5-binding sites and which
are interspersed between upstream VH clusters (Ebert et al.,
2011). A question of interest is whether locus contraction and
decontraction are active mechanisms that occur rapidly in G1-
arrested pro-B cells or whether such genome organizational
changes require cell-cycle progression. Active movement would
potentially have great relevance for chromosomal translocation
mechanisms (see below). Finally, after contraction, more local
movements of VHs in and out of V(D)J recombination centers
theoretically could contribute to balancing their utilization (Lucas
et al., 2011; Figure 2C).
Allelic exclusion of Ig gene expression was discovered based
on allotypic markers that distinguish surface expression of two Ig
alleles (Mostoslavsky et al., 2004). Allelic exclusion results from
productive rearrangement of a single IgH and a single IgL allele
that contribute to the BCR of each newly generated B cell. Allelic
exclusion may be required to allow cellular selection mecha-nisms to efficiently discriminate between cells with self-reactive
and nonself-reactive specificities. However, precise physiologic
roles are enigmatic because allelic exclusion has not been
deregulated at a broad level. Though premature VH81X rear-
rangements on IGCR1-deleted alleles escape feedback regula-
tion, their expression largely is excluded by cellular selection
(Guo et al., 2011b) due to poor pairing of VH81X containing IgH
chains with surrogate IgL chains and their frequent contribution
to autoreactive BCRs (Melchers et al., 2000). Distal VHs do not
rearrange frequently enough in IGCR1 mutants to test for allelic
exclusion. However, locus decontraction mechanisms likely
prevent rearrangement of more distal VHs by spatially isolating
them from DJHs upon formation of productive VH(D)JH alleles
(Hewitt et al., 2010). If so, cis elements that regulate IgH
locus contraction/decontraction must be defined and, if pos-
sible, neutralized to elucidate allelic exclusion roles in normal
physiology.
SHM and IgH Class Switch Recombination
Programmed Genomic Alterations in Mature B Cells
AID-dependent CSR and SHMoccur in response to antigen acti-
vation of B cells in peripheral lymphoid organs such as spleen
and lymph nodes. SHM diversifies primary antibody repertoires
by introducing high-frequency point mutations into IgH and IgL
variable region exons (Di Noia and Neuberger, 2007; Figures
3A and 3B) and occurs in specialized germinal centers (GCs)
where B cells are selected for SHMs that generate BCRs with
increased antigen affinity (Victora and Nussenzweig, 2012).
SHM occurs along V(D)J exons but is focused around 3–4 nucle-
otide-long SHM motifs (Di Noia and Neuberger, 2007). Within
V(D)J exons, SHM motifs are most abundant in three regions
that encode antigen contact portions of IgH and IgL chains,
yielding the most impact of SHM on antigen binding (Di Noia
and Neuberger, 2007). CSR takes place inside and outside of
GCs and replaces Cm with other CHs (e.g., Cg, Cε, and Ca)
from the 200 kb region downstream (Figures 3A and 3C), effect-
ing class switching from IgM to other IgH isotypes (e.g., IgG1,
IgE, IgA, etc.) (Chaudhuri et al., 2007). Long (1–10 kb) repetitive
switch (S) regions, rich in SHM motifs, precede each CH. AID-
dependent DSBs in the donor S region upstream of Cm (Sm)
and a downstream acceptor S region initiate CSR in the G1
phase (Nussenzweig and Nussenzweig, 2010) with end-joining
fusing the two broken S regions to juxtapose the downstream
CH and the V(D)J exon (Figure 3C). CSR is depicted with inherent
‘‘deletional’’ directionality (e.g., Chaudhuri et al., 2007; Fig-
ure 3C). However, in contrast to V(D)J recombination, which
has an inherent directionality provided by requisite coding and
RSS joins, if and how CSR directional joining is imposed are
intriguing questions. Finally, CSR is not allelically excluded and
usually occurs on both IgH alleles (Chaudhuri et al., 2007).
Different Outcomes of AID Activity during SHM and CSR
AID is a small (24 kDa) single-strand (ss) DNA-specific cytidine
deaminase that initiates SHM and CSR (Di Noia and Neuberger,
2007). In this context, AID-generated cytidine deamination
lesions are processed, at least in part, by general cellular base
excision and/or mismatch repair factors to yield mutations in
V(D)J exons during SHM and DSBs (plus mutations) in S regions
during CSR (Di Noia and Neuberger, 2007; Figures 3B and 3C).Cell 152, January 31, 2013 ª2013 Elsevier Inc. 421
How normal repair activities are diverted into generating muta-
tions and DSBs is of great interest. Possibilities include influ-
ences from the nature and/or density of initiating lesions, as
well as potential expression of unknown factors that influence
normal repair outcome. A related question is how AID activity
causes mutations during SHM versus DSBs during CSR (Figures
3B and 3C). One likely factor is target sequence, with S regions
having a higher SHM motif density and being rich in the AGCT
sequence, a palindromic SHM motif that targets AID on both
DNA strands (Han et al., 2011; Xu et al., 2012). More isolated
AID lesions in V regions may be channeled into mutations,
whereas more frequent and dense AID-initiated lesions on
S regions might result in opposing nicks or gaps leading to
DSBs. As SHM and CSR can occur independently, differential
recruitment of downstream factors that influence repair outcome
is another possibility.
Factors that Target AID Activity during SHM and CSR
Factors that bring AID to specific targets are of great interest
given its potent mutagenic activity and expression in nonlym-
phoid cells, including in germ cells, where it has been linked
to reprogramming (Fritz and Papavasiliou, 2010). Transcription
plays a major role in AID targeting. With respect to CSR, tran-
scription targets AID to particular sets of S regions, thereby di-
recting CSR (Chaudhuri et al., 2007; Figures 3A and 3C). In this
regard, each CH has a transcriptional promoter and a noncoding
exon (‘‘I region’’) upstream of the S region. Through cell surface
receptor interactions and cytokine secretion, T cells and other
immune cells activate B cells to turn on particular I region
promoters, with resulting ‘‘germline’’ transcripts running through
associated S regions to provide AID access (Figures 3A and
3C; Chaudhuri et al., 2007). In this way, the immune system
directs CSR to generate antibody classes most suitable for
pathogen elimination. The 30IgH regulatory region (30IgHRR)
downstream of IgH regulates I region promoters and thereby
AID targeting over 100 kb distances (Pinaud et al., 2011). Tran-
scriptional pausing has been implicated in AID targeting (Pavri
and Nussenzweig, 2011). In this regard, AID association with
Spt5, a transcription cofactor activated by RNA polymerase
II pausing, contributes to AID recruitment (Pavri et al., 2010;
Figure 3D).
AID targets both nontemplate and template strands of tran-
scribed duplex DNA during SHM and CSR (Liu and Schatz,
2009). Therefore, once AID arrives, both DNA strands of duplex
DNA targets must be available as ssDNA substrates. Negative
supercoils or other transcriptionally generated structures might
contribute (Longerich et al., 2006). In the latter context, transcrip-
tion of mammalian S regions generates ssDNA within R loops,
providing AID access to the nontemplate strand (Chaudhuri
et al., 2007; Yu and Lieber, 2003). For variable region exons or
frog AGCT-rich S regions that do not favor R loop generation,
transcription-dependent nontemplate strand access can be
promoted in vitro by phosphorylation-dependent AID associa-
tion with replication protein A (RPA), an ssDNA-binding complex
(Chaudhuri et al., 2007; Pavri and Nussenzweig, 2011). Finally,
the RNA exosome, a large RNA degradation complex, provides
AID access to both strands of transcribed AID substrates in vitro,
theoretically via displacement of nascent transcripts (Basu et al.,
2011; Figure 3D). Additional AID-interacting factors potentially422 Cell 152, January 31, 2013 ª2013 Elsevier Inc.implicated in AID targeting have been discussed in depth (Xu
et al., 2012).
Answers to questions of how transcription, target sequences,
and/or cofactors differentially and relatively specifically target
AID will enhance understanding of how collateral damage is
minimized and how highly specific immune responses are gener-
ated. Specific direction of AID activity to different closely linked
targets within the IgH locus is strikingly illustrated by differential
AID targeting into S regions but not into adjacent VH(D)JH exons
during CSR and by robust SHM of VH(D)JH exons in some GC B
cells that have not undergone CSR (Liu and Schatz, 2009;
Figures 3B and 3C). How is such specificity achieved? By
analogy to transcriptional targeting of one versus another closely
linked S region, some aspect of differential transcription of S
regions versus V(D)J exons in the two settings could be involved.
However, as many other genes are transcribed in B cells under-
going SHM and CSR, some of which do provide lower level sites
of ‘‘off-target’’ AID activity (see below), other factors, including
structural aspects of target sequences and/or specific cofactors,
may also play a role. In this regard, elucidating factors that target
AID to V(D)J exons in the GC response may contribute to
designing approaches to elicit certain therapeutic antibodies,
such as broadly neutralizing anti-HIV antibodies that are associ-
ated with extensive SHM (Wu et al., 2011).
DSB End-Joining during V(D)J Recombination and CSR
Classical Nonhomologous End-Joining
The strict dependence of V(D)J recombination on C-NHEJ facil-
itated discovery of this repair pathway (Boboila et al., 2012).
In mammalian cells, C-NHEJ and homologous recombination
(HR) are major DSB repair pathways. HR functions in postrepli-
cation repair and requires large stretches of homology (Bassing
and Alt, 2004; Heyer et al., 2010), whereas C-NHEJ repairs DSBs
throughout the cell cycle, utilizing a spectrum of ends ranging
from those lacking homology (direct joining) to those employing
short microhomologies (MHs) (Boboila et al., 2012). C-NHEJ is
critical for DNA repair in G1-arrested somatic cells in which HR
does not function. DSB repair by end-joining requires DSB
recognition, tethering, processing if needed, and ligation. For
C-NHEJ, the Ku70 and Ku80 end-binding complex (‘‘Ku’’) recog-
nizes DSBs, and the XRCC4 and ligase 4 (Lig 4) complex joins
them (Boboila et al., 2012; Figure 1). C-NHEJ of all types of
broken DNA ends depends on these ‘‘core’’ activities. In addi-
tion, Ku recruits the DNA-dependent protein kinase catalytic
subunit (DNA-PKcs) that activates end processing by the
Artemis endonuclease (Lieber, 2010; Soulas-Sprauel et al.,
2007; Figure 1). Several DNA polymerases may contribute to
end polishing (Lieber, 2010).
C-NHEJ contributes tremendously to diversifying primary
antibody and TCR repertoires by creating diversity in V(D)J
junctions, which encode antigen contact regions (Davis and
Bjorkman, 1988; Bassing et al., 2002). RAG contributes by
generating covalently sealed (hairpin) coding ends and blunt
50-phosphorylated RSS ends (Figure 1). As RAG-cleaved RSS
ends are perfect C-NHEJ substrates, they usually are directly
ligated with no additions or losses. However, hairpin coding
ends must be opened by Artemis, which cleaves at or near the
apex, contributing to deletions and short palindromic insertions
(Lieber, 2010). Terminal deoxynucleotidyl transferase (TdT), a
lymphocyte-specific V(D)J recombination component, further
diversifies repertories by adding nontemplated nucleotide addi-
tions, termed ‘‘N regions,’’ to coding junctions (Bassing et al.,
2002; Figure 1). Junctional diversification mechanisms increase
primary antibody and TCR diversity by many orders of magni-
tude (Davis and Bjorkman, 1988). Restriction of V(D)J joining to
C-NHEJ by RAG also may exclude MH-biased A-EJ pathways
that could restrict diversity. In this regard, certain fetal Ig and
TCR repertoires generated in the absence of TdT have restricted
diversity associated with lack of N regions and repeated ‘‘canon-
ical’’ V(D)J junctions promoted by larger than normal MHs (Gilfil-
lan et al., 1995; Bassing et al., 2002).
Alternative End-Joining
MH-biased A-EJ was discovered via linear plasmid rejoining
assays in C-NHEJ-deficient yeast and mammalian cells and
was later found to function in CSR in the absence of C-NHEJ (Bo-
boila et al., 2012). MH is neither an absolute requirement for nor
an absolute signature of A-EJ (Boboila et al., 2012; Lieber, 2010).
Factors thus far implicated in A-EJ (including XRCC1, Lig3,
PARP1, MRE11, and CtIP) each have critical roles in other
DNA repair pathways (Boboila et al., 2012). Thus, a suggested
working definition of A-EJ, which may reflect several pathways,
is end-joining in the absence of any of the core C-NHEJ factors
(Zhang et al., 2010). Strongly MH-dependent A-EJ in the
absence of XRCC4 or Lig4 likely utilizes Ku and other upstream
C-NHEJ components with a different ligase (Boboila et al.,
2010b; Lieber, 2010). However, B cells lacking Ku or both Ku
and Lig4 also undergoCSR at 20%–40%WT levels and generate
frequent chromosomal translocations by an A-EJ pathway dis-
tinct from C-NHEJ, as it requires neither recognition nor joining
components of C-NHEJ (Boboila et al., 2010b). As CSR in
the absence of Ku plus Lig4 employs more direct joins than
CSR in the absence of Lig4 alone, these two A-EJ pathways
may be different (Boboila et al., 2010b). In this regard, the embyr-
onic lethality of Lig4-deficient mice, which is associated with
severe neuronal apoptosis, is rescued by Ku deficiency (Frappart
and McKinnon, 2008), potentially due to increased access of
neuronal DSBs to an A-EJ pathway suppressed by Ku bound
to DSBs.
The ATM-Dependent DSB Response
DSBs, including those involved in V(D)J recombination, activate
the ATM-dependent DNA damage response (DDR) in which ATM
phosphorylates numerous substrates that mediate cell-cycle
checkpoints and DNA repair (Nussenzweig and Nussenzweig,
2010). ATM-phosphorylated p53 mediates the G1/S checkpoint
that arrests or eliminates cells with unrepaired DSBs (Bassing
and Alt, 2004). ATM also phosphorylates a set of chromatin-
associated proteins, including histone H2AX and 53BP1, that
form foci over hundreds of kilobases flanking DSBs (Nussenz-
weig and Nussenzweig, 2010). Beyond contributing to check-
points, such foci may contribute directly to DSB joining, for
example, by end tethering (Bassing and Alt, 2004). ATM has
a clear role in V(D)J recombination, as ATM deficiency leads to
premature release of some V(D)J coding ends from postcleav-
age RAG complexes and to moderately impaired lymphocyte
development (Helmink and Sleckman, 2012). On the other
hand, deficiency for 53BP1 has only a very modest impact,and deficiency for H2AX has no detectable impact on lympho-
cyte development or V(D)J recombination (Helmink and Sleck-
man, 2012). However, all of these factors actually can serve
more major roles in C-NHEJ during V(D)J recombination, which
are masked by functional redundancies with XRCC4-like factor
(XLF) (Helmink and Sleckman, 2012; Figure 1).
XLF, which interacts with XRCC4, is mutated in radiosensitive,
immunodeficient patients (Lieber, 2010; Soulas-Sprauel et al.,
2007). In this regard, XLF deficiency is associated with lympho-
penia in humans and leads to impaired V(D)J recombination
within extrachromosomal substrates in human fibroblast lines
and mouse embryonic stem cells and embyronic fibroblasts
that ectopically express RAG (Boboila et al., 2012; Soulas-
Sprauel et al., 2007). Yet, XLF deficiency in mice does not mark-
edly impact V(D)J recombination in developing lymphocytes or
pro-B cell lines, which suggested the potential existence of
compensatory factors (Li et al., 2008). Correspondingly, XLF
was found to be functionally redundant with the broader ATM-
dependent DDR for chromosomal V(D)J recombination and
C-NHEJ (Boboila et al., 2012). Thus, mice with combined defi-
ciencies for XLF and ATM or XLF and 53BP1 have severe impair-
ments of V(D)J recombination, lymphocyte development, and
C-NHEJ (Zha et al., 2011; Liu et al., 2012; Oksenych et al.,
2012). Though combined XLF and H2AX deficiency is lethal,
conditional inactivation revealed substantial XLF andH2AX func-
tional redundancy in V(D)J recombination (Zha et al., 2011). The
basis for the functional redundancy between XLF and the ATM-
dependent DDR in chromosomal V(D)J recombination and
C-NHEJ is unknown. One general possibility is redundant func-
tions, for example, in end tethering (Zha et al., 2011). Another
possibility is different functions that are compensatory; for
example, the DDR may tether DSBs, allowing more time for
repair, whereas XLFmay enhance C-NHEJ recruitment, allowing
repair before DSBs separate (Zha et al., 2011).
End-Joining of S Region DSBs during CSR
Joining of many S region DSBs during CSR employs C-NHEJ
(Boboila et al., 2012). In the absence of C-NHEJ, CSR is reduced
to 20%–40% of normal, and many AID-initiated S region DSBs
remain unjoined and progress to chromosome breaks or translo-
cations. As outlined above, residual CSR in C-NHEJ-deficient B
cells is mediated by A-EJ (Boboila et al., 2012). Thus, unlike
RAGs in V(D)J recombination, AID does not chaperone CSR
joining specifically into C-NHEJ. In this context, CSRDSB joining
likely reflects general chromosomal DSB repair via end-joining
(Zarrin et al., 2007). Deficiency for ATM or H2AX alone impairs
CSR more than V(D)J recombination, with levels reduced to
50% of normal (Nussenzweig and Nussenzweig, 2010). Com-
bined deficiency for ATM and XLF further reduces CSR to levels
observed in C-NHEJ-deficient cells with predominantly MH-
mediated junctions, suggesting that ATM and XLF have func-
tional redundancy for C-NHEJ, but not A-EJ (Zha et al., 2011).
Notably, 53BP1 deficiency nearly abrogates CSR, suggesting
specialized 53BP1 CSR roles beyond any served in the general
DDR. Implicated roles include promoting synapsis of two broken
S region ends, protecting them from resection and/or guiding
choice of end-joining pathway (Bothmer et al., 2010, 2011).
Potential 53BP1 CSR roles prior to DSB formation have not
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activated for CSR lead to high levels of AID-dependent IgH chro-
mosome breaks and translocations, similar to C-NHEJ defi-
ciencies. Yet, there is much less general genomic instability
associated with 53BP1 deficiency compared to that observed
in the context of other DDR or C-NHEJ deficiencies (Boboila
et al., 2012), potentially suggesting functional compensation
for 53BP1 deficiency in end-joining outside of CSR.
Mechanisms Promoting CSR versus Intra-S Region DSB
Joining
AID-initiated DSBs within targeted S regions occur very fre-
quently. Within a given S region, some DSBs may simply be
rejoined, whereas others are rejoined with large resections or
joined to other DSBs in the same S region to generate intra-S
deletions (ISDs) (Figure 3C). Unlike RAG, AID does not require
synapsis of two different target sequences to generate DSBs,
raising the question of how the potential intra-S region joining
of DSBs is balanced with inter-S region joining to promote phys-
iological CSR joining levels (Zarrin et al., 2007; Boboila et al.,
2012). Core C-NHEJ factors and 53BP1 may play a role, as in
their absence, S region DSBs are more frequently joined as
ISDs versus CSR junctions (Boboila et al., 2010a; Bothmer
et al., 2010). Notably, the yeast I-SceI meganuclease induces
recombinational class-switching in activated B cells in which S
regions are replaced with I-SceI targets (Zarrin et al., 2007), sug-
gesting that DSB synapsis during CSR evolved to exploit general
cellular mechanisms, such as the DDR or features of three-
dimensional (3D) spatial genome organization (see below). The
ability of I-SceI-mediated IgH DSBs to join to AID-initiated
DSBs 100 kb away in a translocation-like process (Zarrin et al.,
2007) provided the basis for development of high-throughput
genome-wide DSB/translocation cloning approaches that de-
tect genome-wide DSBs via joining to I-SceI- or RAG-generated
DSBs in fixed locations (Chiarle et al., 2011; Klein et al., 2011;
Helmink and Sleckman, 2012).
Mechanisms of Chromosomal Translocations in
Lymphocytes
Roles of Oncogenic Selection and Mechanistic Factors
in Recurrent Translocations
Recurrent oncogenic translocations occur in tumor progenitors
as rare events that are highly selected for impact on cellular pro-
liferation or survival. Activation of oncogenes translocated into Ig
or TCR loci involves their dysregulation by bringing them under
the influence of strong antigen receptor locus enhancers (Janz,
2006). Such enhancer activity has been proven for the 30IgHRR,
which in a mouse lymphoma model, activates c-myc over long
distances subsequent to translocation into IgH (Gostissa et al.,
2011). The 30IgHRR likely serves the same role in many human
tumors with oncogenic IgH translocations (Janz, 2006). How-
ever, basic mechanistic factors also can contribute substantially
to translocation frequency of given sequences and thereby even
influence which oncogenes are translocated in particular tumors
(Gostissa et al., 2009; Wang et al., 2009). At a gross cytogenetic
level, chromosomal translocations are defined as exchanges
between different nonhomologous chromosomes. Cancer ge-
nome analyses revealed that many translocations result from
end-joining of two separate DSBs (Stratton et al., 2009). There-
fore, at a molecular level, genome rearrangements that join two424 Cell 152, January 31, 2013 ª2013 Elsevier Inc.separate DSBs on the same chromosome (e.g., as in CSR)
could be considered translocations. Within a cell population,
several mechanistic variables influence translocation frequency
between two genomic sites (Zhang et al., 2010, 2012; Figure 4A).
A major variable is the frequency of DSBs at each site available
for joining, which itself would be influenced by rate of DSB
initiation and the time that DSBs persist. Another variable is
the frequency with which the two sites are physically juxta-
posed (‘‘synapsed’’). Finally, physically proximal sequences
that harbor DSBs simultaneously must be fused to form a trans-
location, potentially providing additional variables related to
joining pathway access.
Sources of Translocation-Prone DSBs Involved in Ig and
TCR Translocations
RAG- or AID-initiated DSBs introduced into antigen receptor
loci during attempted V(D)J recombination or CSR, respec-
tively, have been implicated in oncogenic translocations found
in many human lymphoid cancers (Gostissa et al., 2011; Rob-
biani and Nussenzweig, 2012). Ablation of RAG or AID in
mouse models confirmed such AID and RAG roles (Gostissa
et al., 2011; Robbiani and Nussenzweig, 2012). AID also may
generate translocation-initiating DSBs in IgL variable region
exons during SHM (Robbiani and Nussenzweig, 2012). Many
RAG-initiated antigen receptor locus DSBs involved in translo-
cations likely are initiated during the normal V(D)J recombina-
tion process within a given Ig or TCR locus (Gostissa et al.,
2011). In this regard, interchromosomal V(D)J recombination
with cryptic RSSs elsewhere in the genome is likely dampened
by 12/23 or B12/23 restrictions and by constraints imposed
by genome organization (see below). However, a role for
interchromosomal V(D)J recombination has been implicated in
the genesis of some oncogenic translocations, such as those
found in certain T-ALLs (Gostissa et al., 2011; Nambiar et al.,
2008).
DSBs that serve as partners for translocation of antigen
receptor locus DSBs, among other sources, could come from
off-target RAG or AID activity. Even though RAG2 binds widely
across the genome (Ji et al., 2010), involvement of RAG in
DSBs outside of antigen receptor loci would likely be subject
to the same restrictions that limit interchromosomal V(D)J re-
combination. However, biochemical studies showed that RAG
nicks cryptic RSSs and non-B DNA structures (Tsai and Lieber,
2010; Schatz and Swanson, 2011). In this regard, analyses of
oncogene translocation hot spots in cancers that arise from
developing human B cells led to the proposal that AID expres-
sion in early B cells targets CpG sites within certain zones, result-
ing in generation of substrates for RAG- and Artemis-dependent
nicking and, ultimately, in generation of DSBs (Tsai and Lieber,
2010; Cui et al., 2012). There is ample evidence that off-target
AID activity leads to DSBs involved in translocations. AID
mutates numerous genes beyond Ig genes in GC B cells and B
cells activated in vitro for CSR (Liu and Schatz, 2009; Pavri and
Nussenzweig, 2011). Moreover, in activated B cells, DSB/trans-
location cloning showed that AID generates off-target DSBs in
various genes, including multiple known B cell oncogenes,
making them the major endogenous source of translocation
hot spots in these cells (Chiarle et al., 2011; Klein et al., 2011).
Going forward, an important goal will be to elucidate off-target
Figure 4. Pre-Existing Spatial Organization
of the Genome Influences Translocations
(A) Cellular heterogeneity of spatial genome
organization allows frequent DSBs to drive recur-
rent translocations. Two genomic loci (a, b) on
heterologous chromosomes are illustrated as red
and blue circles; white lines within them indicate
DSBs; stars indicate translocations. fDSB indi-
cates frequency of available DSBs at a given site;
fsyn represents frequency of cells in the pop-
ulation in which two DSBs are physically juxta-
posed. Comparison of left and right panels
illustrates that frequent DSBs can drive recurrent
translocations of two sequences that are, on
average, not the most proximal in a population.
(B) Pre-existing spatial proximity markedly influ-
ences translocation frequency in the absence of
dominant DSBs. (Left) Schematic of two experi-
mental examples (Zhanget al., 2012) illustrates that
a targetedDSB (gap after red arrowhead) in a given
chromosome translocates much more frequently
along the same chromosome than to other chro-
mosomes. (Right) Translocations from a DSB on
a given chromosome in ATM-deficient, IR-treated,
and G1-arrested transformed pro-B lines are most
frequently formedwith sequences very proximal to
theDSB. Thecurvesare basedonactual data (from
Zhang et al., 2012) shown in schematic form on the
left panel and represent inversional cis trans-
locations (black arrowheads) from the DSB site,
with primer orientation indicated by a red arrow-
head on the chromosome ideogram. Inversional
translocations (IT) clearly involve joining of two
DSBs in this assay and thus are distinguishable
from resections that alsocontribute substantially to
breaksite-proximal junctions (Chiarle et al., 2011).
Black asterisk indicates end of Chr.2. Mb, mega-
bases; Cen, centromeric relative to the DSB; Tel,
telomeric relative to the DSB.AID DSBs and other sources of DSBs in GC B cells, from which
many human lymphomas arise.
Translocation partner DSBs for RAG- or AID-initiated DSBs
may be generated by cell-intrinsic mechanisms, including oxida-
tive and replication stresses, and by transcription (Tsai and
Lieber, 2010; Kim and Jinks-Robertson, 2012; Barlow et al.,
2013 [this issue of Cell]). In activated B cells, transcription is
associated with both AID-initiated and AID-independent DSBs
that are translocation targets (Chiarle et al., 2011; Klein et al.,
2011). Transcription may generate DSBs through various mech-
anisms, including collision with replication forks or generation of
DSB-prone DNA structures (Kim and Jinks-Robertson, 2012). In
the latter context, several DNA sequence-related structures
have been implicated in generating DSBs, including R loops
and non-B DNA structures (Zhao et al., 2010; Kim and Jinks-
Robertson, 2012). As one bona fide example, IgH S regions are
prone to DSBs and, correspondingly, are translocation hot spots
in activated AID-deficient B cells, potentially because they form
R loops or other unstable structures during S region transcription
(Chiarle et al., 2011). Recent studies have shown that regions
containing CpG nucleotides also may be particularly susceptible
to AID-independent replication fork collapse; these regions,
termed ‘‘early replication fragile sites,’’ are found at certain
translocation breakpoints in B cell lymphomas (Barlow et al.,
2013). Finally, various cell-extrinsic agents broadly induce
DSBs; among these are a number of cancer therapeutics, suchas topoisomerase inhibitors and ionizing radiation (IR) (Tsai and
Lieber, 2010).
Role of DSB Persistence in Translocations
Deficiencies for C-NHEJ or DDR responses lead to persistence
of RAG- or AID-initiated DSBs in antigen receptor loci and else-
where that progress into translocations (Zhang et al., 2010).
Dangers associated with such persistence are controlled in
many cases by strict checkpoints that eliminate cells with per-
sisting DSBs, for example, the p53-dependent G1 checkpoint
(Helmink and Sleckman, 2012). In the latter context, combined
deficiency for C-NHEJ and p53 or H2AX and p53 predisposes
to recurrent pro-B lymphomas with RAG-initiated IgH to c-myc
translocations, whereas deficiency for any one of these factors
does not (Gostissa et al., 2011). ATM deficiency, which impacts
both V(D)J joining and the p53-dependent G1 checkpoint, pre-
disposes to B and/or T cell lymphomas with V(D)J recombina-
tion-associated oncogenic translocations in humans and mice
(Helmink and Sleckman, 2012). In RAG-expressing ATM-defi-
cient pro-B cell lines, DSB/translocation-cloning hot spots,
besides IgH and IgL, include various TCR loci, demonstrating
that persistence allows RAG-initiated DSBs at relatively inac-
cessible antigen receptor locus RSSs to become recurrent
translocation targets (Zhang et al., 2012). In ATM-deficient
mice, RAG-initiated IgH DSBs generated at the pro-B stage
lead to chromosomal breaks in peripheral B cells that provide
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translocations (Calle´n et al., 2007). Whether such RAG-initiated
chromosomal breaks actually persist or, rather, lead to genera-
tion of new sets of DSBs via a breakage-fusion-bridge type
of mechanism, as observed in the dual absence of C-NHEJ
and p53 (Bassing and Alt, 2004; Nussenzweig and Nussenzweig,
2010), remains to be determined. Finally, receptor editing in the
periphery may also contribute to translocations (Wang et al.,
2009).
End-Joining of DSBs to Form Translocations
C-NHEJ-deficient cells often accumulate substantial levels of
prereplicative chromosome breaks as well as chromosomal
translocations (e.g., Yan et al., 2007; Franco et al., 2008; Boboila
et al., 2010a), consistent with the major role of C-NHEJ in the G1
phase (Gostissa et al., 2011). In this regard, characterized trans-
location junctions in C-NHEJ-deficient primary lymphocytes and
tumors are generated by end-joining, as opposed to HR-related
mechanisms, and thusmust be catalyzed by A-EJ (Boboila et al.,
2012). However, a critical question is whether A-EJ is a translo-
cation-prone pathway that can drive translocations in the pres-
ence of C-NHEJ or whether its predominance in the absence
of C-NHEJ reflects an abundance of persistent DSBs that drive
a less-efficient DSB-joining reaction. In this context, some
studies suggest that A-EJ is especially prone to generating
translocations (Simsek and Jasin, 2010). Although a role for
C-NHEJ in generating translocation junctions has not been ruled
out, C-NHEJ has been suggested to normally suppress translo-
cations via a propensity to join DSBs intrachromosomally, poten-
tially in association with the DDR and enhanced by 3D spatial
proximity effects (Boboila et al., 2012; see below).
Role of Spatial Genome Organization in Guiding
Translocations
One model for DSB synapsis prior to translocation posits DSB
movement, whereas another posits synapsis of translocating
sequences prior to DSB formation (Misteli and Soutoglou,
2009). Cytogenetic studies correlated proximity of two loci in
the mammalian interphase nucleus with involvement in translo-
cations (Misteli and Soutoglou, 2009), supporting the pre-exist-
ing synapsis model. Though large-scale DSB movements occur
in yeast (Dion et al., 2012; Mine´-Hattab and Rothstein, 2012),
evidence for mammalian DSB movement is more limited (Misteli
and Soutoglou, 2009).Most notably, 53BP1 promotesmobility of
uncapped telomeres, which resemble DSBs, and their fusion by
end-joining (Dimitrova et al., 2008). More locally, DSB mobility
via Brownian motion also might contribute to synapsis of prox-
imal DSBs (Misteli and Soutoglou, 2009; Zhang et al., 2012).
Both G1-arrested and cycling human cells display cellular
heterogeneity in spatial genome organization, allowing loci
that on average are not highly proximal in cell populations to
be spatially proximal within some cells (Imakaev et al., 2012).
Thus, when considering a cell population, translocation fre-
quency of two DSB sites that do not actively move should reflect
products of factors related to available DSB frequency at each
site (e.g., [fDSBa 3 fDSBb]) and a factor describing their
synapsis frequency within the population (fsyn) (Zhang et al.,
2012; Figure 4A). Correspondingly, cellular heterogeneity in
spatial genome organization allows frequent DSBs to drive
recurrent translocations of loci not considered highly proximal
by classical cytogenetic approaches, providing an explanation426 Cell 152, January 31, 2013 ª2013 Elsevier Inc.for how 40 pairs of targeted DSBs on various chromosomes
translocate recurrently in G1-arrested pro-B lines (Zhang et al.,
2012) and how AID-dependent DSBs translocate to target
DSBs at a higher frequency than predicted by average proximity
(Hakim et al., 2012). This model also may explain interchromo-
somal CSR (Pinaud et al., 2011), which could be driven by fre-
quent, simultaneous S region DSBs on both IgH alleles (Chiarle
et al., 2011).
When DSB frequencies at one or both of the potentially trans-
locating loci are not dominant compared to those of other DSBs
genome wide, factors that influence pre-existing spatial prox-
imity of two loci can markedly influence potential translocation
target landscapes (Figure 4B). Such factors include lying in
active versus inactive chromatin compartments, being actively
transcribed, being on similar-sized chromosomes, and most
notably being on the same chromosome (Mahowald et al.,
2009; Chiarle et al., 2011; Hakim et al., 2012; Klein et al., 2011;
Zhang et al., 2012). In the latter context, fluorescence in situ
hybridization (FISH) andHi-C experiments show thatmammalian
chromosomes have territories in both cycling and G1-arrested
cell populations, such that intrachromosomal interactions occur
far more frequently than interchromosomal interactions (Ima-
kaev et al., 2012; Marti-Renom and Mirny, 2011; Zhang et al.,
2012). Correspondingly, in G1-arrested, ATM-deficient pro-B
lines treatedwith IR to normalize DSBs genomewide, this aspect
of intrachromosomal spatial genome organization causes
regions along the entire length of an individual chromosome to
become hot spots for translocations of DSBs introduced in cis
into that chromosome (Zhang et al., 2012; Figure 4B). Likewise,
translocations in tumor cells subsequent to DSB-inducing
chemotherapies or radiotherapies might be similarly influenced.
The propensity of two DSBs to join intrachromosomally also
might lead to recurrent intrachromosomal deletions associated
with T-ALLs and other cancers if involved regions are structurally
or otherwise prone to DSBs (O’Neil and Look, 2007; Solimini
et al., 2012). It may contribute as well to extensive intrachromo-
somal cancer genome rearrangements known as chromothripsis
(Maher and Wilson, 2012).
DSB/translocation cloning analyses of inversional transloca-
tion junctions in G1-arrested, ATM-deficient pro-B lines in which
DSBs are normalized across the genome via IR revealed that in-
trachromosomal translocation frequencies are further elevated
in several hundred kilobase regions flanking DSBs (Zhang
et al., 2012; Figure 4B). Given that two random DSBs would
rarely occur within such short genomic distances, this phenom-
enon would most greatly impact joining of closely linked recur-
rent DSBs, such as AID-initiated S region DSBs during CSR
(Zarrin et al., 2007). Though additional studies in wild-type and
various other mutant backgrounds should help to resolve poten-
tial mechanisms underlying this phenomenon, there are several
general possibilities—not mutually exclusive—that can be con-
sidered. One is that perturbations of local chromatin structure
around a DSB or activation and recruitment of repair machinery
in association with a DSB might contribute to enhanced joining
with proximal DSBs (Bassing and Alt, 2004; Downs et al.,
2007; Zarrin et al., 2007). Another is that such shorter-range
enhancement of intrachromosomal joining of separate DSBs
may reflect pre-existing spatial proximity influences at a more
local level. In this regard, Hi-C analyses indicate that contacts
between loci within a 1Mb distance aremore frequent than other
intrachromosomal interactions, suggesting that chromatin is
more organized at shorter distances and that contacts over
longer distances occur stochastically in only a subset of cells
(Fudenberg and Mirny, 2012), consistent with mammalian chro-
mosomes being organized into megabase-sized topological
domains (Dixon et al., 2012). Such local influences of pre-exist-
ing genome organization at the megabase, or potentially subme-
gabase, scale also might contribute to synapsis of VHs and the
DJH prior to RAG cutting (Lucas et al., 2011) and conceivably
provide a mechanistic basis for highly preferential proximal VH
rearrangement.
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